debrisoquin has been researched along with desmethylclomipramine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brøsen, K; Gram, LF; Nielsen, KK | 1 |
| Balant, L; Balant-Gorgia, AE; Zysset, T | 1 |
1 trial(s) available for debrisoquin and desmethylclomipramine
| Article | Year |
|---|---|
Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
Topics: Adult; Aged; Clomipramine; Cytochrome P-450 Enzyme System; Debrisoquin; Depression; Female; Humans; Male; Middle Aged; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Sparteine | 1992 |
1 other study(ies) available for debrisoquin and desmethylclomipramine
| Article | Year |
|---|---|
High plasma concentrations of desmethylclomipramine after chronic administration of clomipramine to a poor metabolizer.
Topics: Allopurinol; Clomipramine; Debrisoquin; Depressive Disorder; Female; Humans; Hydroxylation; Kinetics; Middle Aged | 1987 |